Accessibility Menu
Neuphoria Therapeutics Stock Quote

Neuphoria Therapeutics (NASDAQ: NEUP)

$4.54
(-6.4%)
-0.31
Price as of October 22, 2025, 10:00 a.m. ET

KEY DATA POINTS

Current Price
$4.54
Daily Change
(-6.4%) $0.31
Day's Range
$4.3 - $4.85
Previous Close
$4.85
Open
$4.85
Beta
0.59
Volume
201,156
Average Volume
123,191
Market Cap
9.1M
Market Cap / Employee
$4.85M
52wk Range
$2.12 - $21.4
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$23.89
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Neuphoria Therapeutics Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
NEUP+36.77%N/AN/A-27%
S&P+15.06%+95.03%+14.29%+12%

Neuphoria Therapeutics Company Info

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Financial Health

General

Q1 2025YOY Change
Revenue$15.00M0.0%
Gross Profit$14.83M9052.5%
Gross Margin98.90%0.0%
Market Cap$10.12M1002.7%
Net Income$11.26M505.4%
EBITDA$12.14M644.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q1 2025YOY Change
Net Cash$17.04M0.0%
Accounts Receivable$0.10M0.0%
Inventory00.0%

Liabilities

Q1 2025YOY Change
Long Term Debt$0.02M0.0%
Short Term Debt$0.15M0.0%

Ratios

CurrentYOY Change
Return On Invested Capital-54.23%-9.2%

Cash Flow

Q1 2025YOY Change
Free Cash Flow$11.22M435.0%
Operating Free Cash Flow$11.22M435.0%

Valuation

MetricQ2 2024Q3 2024Q4 2024Q1 2025YoY Change
Price to Book74.5280.24625.910.68-99.32%
Price to Sales8.150.63-
Price to Tangible Book Value19.0531.373733.0945.8679.26%
Price to Free Cash Flow TTM21.24-
Enterprise Value to EBITDA2.16-360.31-0.35-0.57-
Free Cash Flow Yield4.7%-
Total Debt$0.27M$0.25M$0.17M$0.17M-

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.